<table border="0" cellpadding="0" cellspacing="0" width="617" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 1: Select Mean (±SD) Metformin Pharmacokinetic Parameters Following Single or Multiple Oral Doses of Metformin  
			</caption>
<thead>
<tr>
<th align="center" stylecode="Lrule Rrule Toprule">Subject Groups: Metformin Dose<sup>a</sup>
<br/>(number of subjects)</th>
<th align="center" stylecode="Lrule Rrule Toprule">C<sub>max</sub>b<br/>(mcg/mL)</th>
<th align="center" stylecode="Lrule Rrule Toprule">T<sub>max</sub>
<sup>c</sup>
<br/>(hrs)</th>
<th align="center" stylecode="Lrule Rrule Toprule">Renal <br/>Clearance <br/>(mL/min)</th>
</tr>
</thead>
<tfoot>
<tr>
<td colspan="4">
<sup>a </sup>All doses given fasting except the first 18 doses of the multiple-dose studies <br/>
<sup>b</sup> Peak plasma concentration <br/>
<sup>c</sup> Time to peak plasma concentration<br/>
<sup>d</sup> SD=single dose <br/>
<sup>e</sup> Combined results (average means) of 5 studies: mean age 32 years (range 23 to 59 years)<br/>
<sup>f</sup> Kinetic study done following dose 19, given fasting <br/>
<sup>g </sup>Elderly subjects, mean age 71 years (range 65 to 81 years)<br/>
<sup>h</sup> CL<sub>cr</sub>=creatinine clearance normalized to body surface area of 1.73 m<sup>2</sup>
<br/>
</td>
</tr>
</tfoot>
<tbody>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule" valign="top">
<content stylecode="bold"> Healthy, nondiabetic adults:</content>
<br/> 500 mg SD<sup>d</sup> (24)<br/> 850 mg SD (74)<sup>e</sup>
<br/> 850 mg t.i.d. for 19 doses<sup>f</sup> (9) <br/>
</td>
<td align="center" stylecode="Rrule" valign="top">1.03 (±0.33) <br/>1.6 (±0.38) <br/>2.01 (±0.42)<br/>
</td>
<td align="center" stylecode="Rrule" valign="top">2.75 (±0.81) <br/>2.64 (±0.82)<br/>1.79 (±0.94)<br/>
</td>
<td align="center" stylecode="Rrule" valign="top">600 (±132) <br/>552 (±139) <br/>642 (±173)<br/>
</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule" valign="top">
<content stylecode="bold"> Adults with type 2 diabetes:</content>
<br/> 850 mg SD (23)<br/> 850 mg t.i.d. for 19 doses<sup>f</sup> (9)<br/>
</td>
<td align="center" stylecode="Rrule" valign="top">1.48 (±0.5)<br/>1.9 (±0.62)<br/>
</td>
<td align="center" stylecode="Rrule" valign="top">3.32 (±1.08)<br/>2.01 (±1.22)<br/>
</td>
<td align="center" stylecode="Rrule" valign="top">491 (±138) <br/>550 (±160)<br/>
</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule" valign="top">
<content stylecode="bold"> Elderly<sup>g</sup>, healthy nondiabetic adults:</content>
<br/> 850 mg SD (12) <br/>
</td>
<td align="center" stylecode="Rrule" valign="top">2.45 (±0.7)<br/>
</td>
<td align="center" stylecode="Rrule" valign="top">2.71 (±1.05)<br/>
</td>
<td align="center" stylecode="Rrule" valign="top">412 (±98)<br/>
</td>
</tr>
<tr>
<td stylecode="Lrule Rrule" valign="top">
<content stylecode="bold"> Renal-impaired adults: 850 mg  SD</content>
<br/> Mild (CL<sub>cr</sub>
<sup>h</sup> 61-90 mL/min) (5) <br/> Moderate (CL<sub>cr</sub> 31-60 mL/min)  (4) <br/> Severe (CL<sub>cr</sub> 10-30 mL/min) (6) <br/>
</td>
<td align="center" stylecode="Rrule" valign="top">1.86 (±0.52) <br/>4.12 (±1.83) <br/>3.93 (±0.92)<br/>
</td>
<td align="center" stylecode="Rrule" valign="top">3.2 (±0.45)<br/>3.75 (±0.5)<br/>4.01 (±1.1)<br/>
</td>
<td align="center" stylecode="Rrule" valign="top">384 (±122)<br/>108 (±57)<br/>130 (±90)<br/>
</td>
</tr>
</tbody>
</table>